← ANALYSTS · TIPRANKS
Charles Zhu · LifeSci Capital
Hits
64%
145 of 228 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+25.8%
Over a year after the rating, TipRanks’ measure
Our companies rated now
12
Buy / hold / sell: 10 / 2 / 0
Upside of the analyst’s targets
+249.5%
Average over 11 current targets, to the last price
The market’s answer to the ratings
+10.1%
Day-0 move against SPY in the rating’s direction, average over 3 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 5on TipRanks 12:45 | IMNMIWMImmunome · $2.1B | Reiterated | Buy | $40.00 | +142.9% | +0.6%next day −9.3% · 5 days −10.0% | ↗ |
| Oct 5on TipRanks 10:55 | RVMDRevolution Medicines · $41.5B | Reiterated | Buy | $315 | +77.0% | −0.2%next day −4.3% · 5 days −7.0% | ↗ |
| Oct 5on TipRanks 10:35 | CBIOIWMCrescent Biopharma · $464M | Reiterated | Buy | $28.00 | +136.5% | −3.3%next day −3.2% · 5 days +3.3% | ↗ |
| Oct 3on TipRanks Oct 5 03:25 | RCUSIWMArcus Biosciences · $2.9B | Reiterated | Buy | $46.00 | +108.0% | +0.6%next day −2.4% · 5 days −2.0% | ↗ |
| Sep 30on TipRanks 11:06 | IMNMIWMImmunome · $2.1B | Reiterated | Buy | $40.00 | +142.9% | −1.5%next day −3.1% · 5 days −13.1% | ↗ |
| Sep 28on TipRanks 12:55 | ZYMEIWMZymeworks · $1.8B | Reiterated | Buy | $34.00 | +35.8% | +3.0%next day +0.5% · 5 days −4.6% | ↗ |
| Sep 27on TipRanks 19:25 | IDYAIWMIDEAYA Biosciences · $3.3B | Reiterated | Buy | $58.00 | +76.6% | +4.9%next day −0.8% · 5 days −1.6% | ↗ |
| Sep 27on TipRanks 19:15 | RCUSIWMArcus Biosciences · $2.9B | Reiterated | Buy | $46.00 | +108.0% | +0.9%next day +2.7% · 5 days −2.3% | ↗ |
| Sep 22on TipRanks 14:35 | CMPXIWMCompass Therapeutics · $158M | Downgrade | Hold | — | — | −31.9%next day −4.9% · 5 days −10.1% | ↗ |
| Aug 13on TipRanks 13:25 | PBLSIWMParabilis Medicines, Inc. · $3.1B | Reiterated | Buy | $42.00 | +84.6% | −5.3%next day +4.1% · 5 days +12.9% | ↗ |
| Aug 13on TipRanks 06:35 | KURAIWMKura Oncology · $863M | Reiterated | Buy | $28.00 | +208.4% | +0.8%next day +7.8% · 5 days +18.0% | ↗ |
| Aug 12on TipRanks 09:35 | STROIWMSutro Biopharma · $190M | Reiterated | Buy | $54.00 | +393.6% | −15.2%next day −0.6% · 5 days +3.3% | ↗ |
| Aug 11on TipRanks 19:05 | TARAIWMProtara Therapeutics · $142M | Assigned | Buy | $22.00 → $20.00−9.1% | +762.1% | −0.8%next day +0.6% · 5 days +2.2% | ↗ |
| Aug 8on TipRanks Aug 6 16:37 | CNTXIWMContext Therapeutics · $22M | Downgrade | Hold | $2.00 | +719.7% | −4.6%next day −6.6% · 5 days +7.5% | ↗ |
| Jul 30on TipRanks 16:35 | CBIOIWMCrescent Biopharma · $464M | Reiterated | Buy | $28.00 | +136.5% | −4.4%next day +1.3% · 5 days +12.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗